在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

AGL Recombinant Monoclonal Antibody

  • 中文名稱:
    AGL Recombinant Monoclonal Antibody
  • 貨號:
    CSB-RA116104A0HU
  • 規格:
    ¥1320
  • 圖片:
    • IHC image of CSB-RA116104A0HU diluted at 1:100 and staining in paraffin-embedded human liver tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.05% DAB.
    • Overlay Peak curve showing Hela cells stained with CSB-RA116104A0HU (red line) at 1:100. The cells were fixed in 4% formaldehyde and permeated by 0.2% TritonX-100 for?10min. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*106cells) for 45min at 4℃. The secondary antibody used was FITC-conjugated goat anti-rabbit IgG (H+L) at 1/200 dilution for 35min at 4℃.Control antibody (green line) was Rabbit IgG (1ug/1*106cells) used under the same conditions. Acquisition of >10,000 events was performed.
  • 其他:

產品詳情

  • Uniprot No.:
  • 基因名:
    AGL
  • 別名:
    Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase), Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)], AGL, GDE
  • 反應種屬:
    Human
  • 免疫原:
    A synthesized peptide from human AGL protein
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    Non-conjugated
  • 克隆類型:
    Monoclonal
  • 抗體亞型:
    Rabbit IgG
  • 純化方式:
    Affinity-chromatography
  • 克隆號:
    8D4
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 產品提供形式:
    Liquid
  • 應用范圍:
    ELISA, IHC, FC
  • 推薦稀釋比:
    Application Recommended Dilution
    IHC 1:50-1:200
    FC 1:50-1:200
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation.
  • 基因功能參考文獻:
    1. This report of patients with GSD-III in Iran with 2 uncommon clinical presentations and 5 novel mutations in the AGL gene. PMID: 29794575
    2. The study identified 31 novel mutations and extended the mutation spectrum of AGL in Chinese patients with glycogen storage disease type III. PMID: 26984562
    3. Our study establishes HAS2-mediated HA synthesis as a driver of growth of bladder cancer with low AGL and provides preclinical rationale for personalized targeting of HAS2/HA signaling in patients with low amylo-alpha-1-6-glucosidase-4-alpha-glucanotransferase -expressing tumors. PMID: 26490312
    4. AGL loss causes high SHMT2 expression and consequently increases glycine-dependent nucleotide synthesis leading to bladder cancer growth. PMID: 26975021
    5. Point mutations in AGL gene are associated with glycogen storage disease type IIIa in a Chinese family. PMID: 26252094
    6. Haplotype analysis revealed that the mutation arises as a result of founder effect, not an independent event. PMID: 25827695
    7. AGL haplotype analyses suggested that c.1019delA and c.958+1G>A are founder mutations in Turkish patients, while p.R864X is a recurrent mutation. PMID: 25451950
    8. A homozygous frameshift deletion, c.4456delT, in exon 33 of the AGL gene in Inuit children determines the cause of glycogen storage disease type IIIa and confirms a founder effect. PMID: 25602008
    9. study identified 10 different mutations in 8 Korean Glycogen storage disease type III patients; 5 mutations are novel and include 1 nonsense (c.1461G>A, p.W487X), 3 splicing (c.293+4_293+6delAGT in IVS4, c.460+1G>T in IVS5, c.2682-8A>G in IVS21) and 1 missense mutation (c.2591G>C, p.R864P) PMID: 24257475
    10. Characterization of a novel homozygous single point mutation at the polypyrimidine tract of intron 21 of the AGL gene in two consanguineous siblings with glycogen storage disease type III. PMID: 23649758
    11. We found that most patients with macular telangiectasia-2 possess retinal autoantibodies, the most prevalent of which were directed against AGL, RBP3, and CK-B. PMID: 23882694
    12. A founder effect discovered amongst Tunisian patients with glycogen storage disease type III and a c.3216_3217delGA mutation in the AGL gene. PMID: 22035446
    13. Mutations in amylo-1,6-glucosidase is associated with Glycogen Storage Disease Type III. PMID: 20648714
    14. The present patient was found to be deficient in GDE activity and homozygous for a novel 1 bp deletion in AGL. This mutation is predicted to cause premature termination at codon 834 due to frame shift. PMID: 20158661
    15. GSD-III patients have variable phenotypic characteristics. Administration of raw-corn-starch can effectively improve the disease outcome. We identified 8 new mutations on AGL gene through nucleotide sequence analysis. PMID: 15833157
    16. Nine AGL mutations: six nonsense mutations , one deletion and two splicing mutation were identified in Turkish GSD III patients. PMID: 19834502
    17. Mutations associated with GSD III include R34X and Y1148X. PMID: 11924557
    18. it is likely that the AMPK-GDE association is a novel mechanism regulating AMPK activity and the resultant fatty acid oxidation and glucose uptake PMID: 15886229
    19. AGL gene mutations may have roles in glycogen storage disease type III PMID: 17047887
    20. These results indicate that binding to glycogen crucially regulates the stability of AGL and, further, that its ubiquitination may play an important role in the pathophysiology of both Lafora and Cori's disease. PMID: 17908927
    21. Current clinical and molecular knowledge about glycogenosis 3 and phenotype and genotype levels of this enzyme. [REVIEW] PMID: 17915576
    22. a homozygous p.W1327X mutation leads to severe generalized glycogenosis types 3a & 3b within the same family; heterozygous p.W1327X mutation carriers may present with mild non-progressive neuromuscular symptoms, such as exercise-induced myalgia & fatigue PMID: 18924225
    23. Mutations in the carbohydrate-binding domain of AGL lead to loss of all enzymatic activities and enhancing targeting for proteasomal degradation. PMID: 19299494
    24. Six novel AGL mutations were identified. PMID: 19754354

    顯示更多

    收起更多

  • 相關疾病:
    Glycogen storage disease 3 (GSD3)
  • 亞細胞定位:
    Cytoplasm. Note=Under glycogenolytic conditions localizes to the nucleus.
  • 蛋白家族:
    Glycogen debranching enzyme family
  • 組織特異性:
    Liver, kidney and lymphoblastoid cells express predominantly isoform 1; whereas muscle and heart express not only isoform 1, but also muscle-specific isoform mRNAs (isoforms 2, 3 and 4). Isoforms 5 and 6 are present in both liver and muscle.
  • 數據庫鏈接:

    HGNC: 321

    OMIM: 232400

    KEGG: hsa:178

    STRING: 9606.ENSP00000294724

    UniGene: Hs.904



主站蜘蛛池模板: 丝袜人妻一区二区三区| 蜜臀av夜夜澡人人爽人人| 国产精品亲子乱子伦xxxx裸| 久久国产精品无码hdav| 99久久免费国产精品四虎| 波多野结衣潮喷视频无码42| 精品国产三级a∨在线| 俄罗斯美女真人性做爰| 国产成人精品久久久久精品日日| 50岁熟妇的呻吟声对白| 人妻熟女一区二区aⅴ千叶宁真 | 精品国产成人网站一区在线| 亚洲精品一区二区三区四区乱码 | 国内精品久久久久久不卡影院| 色综合中文综合网| 无码精品a∨在线观看无广告| 欧美国产日韩亚洲中文| 日本熟妇中文字幕三级| 青草青草久热精品视频在线观看 | 国产伦精品一区二区三区免费迷| 忘忧草日本在线www| 乌克兰美女浓毛bbw| 亚洲中文字幕一区精品自拍 | 亚洲色大18成人网站www在线播放| 久久精品国产只有精品2020| 影音先锋久久久久av综合网成人| 永久免费看mv网站入口亚洲| 色妺妺av爽爽影院| 色综合久久婷婷五月| 成年女人免费视频播放体验区 | 国产乱理伦片在线观看| 女人与拘性猛交视频| 华人在线亚洲欧美精品| 亚洲欧美日韩另类精品一区| 夜夜嗨av一区二区三区| 99热这里只有精品最新地址获取| 色又黄又爽18禁免费网站| 国产农村妇女毛片精品久久| 亚洲国产另类久久久精品黑人| 亚洲中文字幕在线精品2021| 牲交欧美兽交欧美|